Albuterol HFA MDI

albuterol · Teva Branded Pharmaceutical Products R&D, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Albuterol HFA MDI, covering 2009-12-03 to 2022-08-31. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of Single-Dose Efficacy of an Albuterol Breath-Actuated Inhaler (Albuterol-HFA-BAI) Versus an Albuterol Metered-Dose Inhaler (Albuterol-HFA-MDI) in Participants With Asthma [Phase 4]

See pricing